MDGL
Madrigal Pharmaceuticals Inc
513.20$
+0.0%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | -921.9% | -107.7% | -101.1% | -64.8% | -22.1% | 27.8% | -41.6% | -53.8% | 6.4% | -15.4% | |
| – | – | – | 1.8% | 0.5% | 0.4% | 0.3% | 0.2% | 0.8% | 0.1% | 0.1% | 0.1% | 0.3% | |
| – | – | – | 166.7% | 28.8% | 17.1% | 15.3% | 11.8% | 9.1% | 8.0% | 10.9% | 9.7% | 9.5% | |
| – | – | – | -55.5% | 35.0% | -61.6% | -27.3% | -14.9% | 56.8% | -31.9% | -34.0% | -7.4% | -5.6% | |
| – | – | – | 35.1% | 1.3% | 0.2% | 0.0% | 0.0% | 0.3% | 0.1% | 1.2% | 1.2% | 0.7% | |
| – | – | – | -834.1% | -325.5% | -46.4% | 119.4% | 22.5% | -72.1% | 8.6% | 61.7% | 9.4% | 3.7% | |
| – | – | – | – | 0.0% | 0.0% | – | – | – | 0.0% | – | – | – | |
| – | – | – | 916.3% | 12.0% | 19.1% | 6.3% | 0.8% | 82.4% | 2.8% | 0.7% | 0.9% | 19.6% | |
| – | – | – | -839.7% | -421.3% | -128.4% | 60.9% | 1.2% | 38.1% | -30.2% | 9.1% | 16.7% | 7.9% | |
| – | – | – | -956.9% | -109.0% | -101.3% | -64.8% | -22.1% | 27.5% | -41.4% | -55.0% | 5.2% | -16.1% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.